172 related articles for article (PubMed ID: 38683770)
41. Current management of endometrial hyperplasia and endometrial intraepithelial neoplasia (EIN).
Gültekin M; Diribaş K; Dursun P; Ayhan A
Eur J Gynaecol Oncol; 2009; 30(4):396-401. PubMed ID: 19761130
[TBL] [Abstract][Full Text] [Related]
42. Improving the Diagnosis of Endometrial Hyperplasia Using Computerized Analysis and Immunohistochemical Biomarkers.
Sanderson PA; Esnal-Zufiaurre A; Arends MJ; Herrington CS; Collins F; Williams ARW; Saunders PTK
Front Reprod Health; 2022; 4():896170. PubMed ID: 36303676
[TBL] [Abstract][Full Text] [Related]
43. Preoperative and postoperative agreement of histopathological findings in cases of endometrial hyperplasia.
Kleebkaow P; Maneetab S; Somboonporn W; Seejornj K; Thinkhamrop J; Kamwilaisak R
Asian Pac J Cancer Prev; 2008; 9(1):89-91. PubMed ID: 18439083
[TBL] [Abstract][Full Text] [Related]
44. Management of endometrial precancers.
Trimble CL; Method M; Leitao M; Lu K; Ioffe O; Hampton M; Higgins R; Zaino R; Mutter GL;
Obstet Gynecol; 2012 Nov; 120(5):1160-75. PubMed ID: 23090535
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic and Treatment Reproducibility of Cervical Intraepithelial Neoplasia / Squamous Intraepithelial Lesion and Factors Affecting the Diagnosis.
Sağlam A; Usubütün A; Dolgun A; Mutter GL; Salman MC; Kurtulan O; Akyol A; Özkan EA; Baykara S; Bülbül D; Calay Z; Eren F; Gümürdülü D; Haberal N; Ilvan Ş; Karaveli Ş; Koyuncuoğlu M; Müezzinoğlu B; Müftüoğlu KH; Özen Ö; Özdemir N; Peştereli E; Ulukuş Ç; Zekioğlu O
Turk Patoloji Derg; 2017; 1(1):177-191. PubMed ID: 28832077
[TBL] [Abstract][Full Text] [Related]
46. Comparison of the reproducibility of the WHO classifications of 1975 and 1994 of endometrial hyperplasia.
Skov BG; Broholm H; Engel U; Franzmann MB; Nielsen AL; Lauritzen AF; Skov T
Int J Gynecol Pathol; 1997 Jan; 16(1):33-7. PubMed ID: 8986530
[TBL] [Abstract][Full Text] [Related]
47. A New Hysteroscopic Risk Scoring System for Diagnosing Endometrial Hyperplasia and Adenocarcinoma.
Ianieri MM; Staniscia T; Pontrelli G; Di Spiezio Sardo A; Manzi FS; Recchi M; Liberati M; Ceccaroni M
J Minim Invasive Gynecol; 2016; 23(5):712-8. PubMed ID: 26940400
[TBL] [Abstract][Full Text] [Related]
48. Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling.
Gawron I; Łoboda M; Babczyk D; Ludwin I; Basta P; Pityński K; Ludwin A
Przegl Lek; 2017; 74(4):139-43.. PubMed ID: 29696944
[TBL] [Abstract][Full Text] [Related]
49. Diagnosis and management of endometrial hyperplasia.
Armstrong AJ; Hurd WW; Elguero S; Barker NM; Zanotti KM
J Minim Invasive Gynecol; 2012; 19(5):562-71. PubMed ID: 22863972
[TBL] [Abstract][Full Text] [Related]
50. Histopathologic diagnosis of endometrial precancers: Updates and future directions.
Chen H; Strickland AL; Castrillon DH
Semin Diagn Pathol; 2022 May; 39(3):137-147. PubMed ID: 34920905
[TBL] [Abstract][Full Text] [Related]
51. Cellular features of endometrial hyperplasia and well differentiated adenocarcinoma using the Endocyte sampler: Diagnostic criteria based on the cytoarchitecture of tissue fragments.
Norimatsu Y; Shimizu K; Kobayashi TK; Moriya T; Tsukayama C; Miyake Y; Ohno E
Cancer; 2006 Apr; 108(2):77-85. PubMed ID: 16463402
[TBL] [Abstract][Full Text] [Related]
52. A serum lipidomics study for the identification of specific biomarkers for endometrial polyps to distinguish them from endometrial cancer or hyperplasia.
Yan X; Zhao W; Wei J; Yao Y; Sun G; Wang L; Zhang W; Chen S; Zhou W; Zhao H; Li X; Xiao Y; Li Y
Int J Cancer; 2022 May; 150(9):1549-1559. PubMed ID: 35076938
[TBL] [Abstract][Full Text] [Related]
53. Study on the morphology and reproducibility of the diagnosis of endometrial lesions utilizing liquid-based cytology.
Papaefthimiou M; Symiakaki H; Mentzelopoulou P; Tsiveleka A; Kyroudes A; Voulgaris Z; Tzonou A; Karakitsos P
Cancer; 2005 Apr; 105(2):56-64. PubMed ID: 15751019
[TBL] [Abstract][Full Text] [Related]
54. Loss of B-cell lymphoma 2 immunohistochemical expression in endometrial hyperplasia: A specific marker of precancer and novel indication for treatment: A systematic review and meta-analysis.
Travaglino A; Raffone A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
Acta Obstet Gynecol Scand; 2018 Dec; 97(12):1415-1426. PubMed ID: 30168854
[TBL] [Abstract][Full Text] [Related]
55. [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology].
Lax S
Pathologe; 2011 Nov; 32 Suppl 2():255-64. PubMed ID: 22033684
[TBL] [Abstract][Full Text] [Related]
56. [New views on hyperplastic endometrial lesions classification--endometrial intraepithelial neoplasia (EIN)].
Sobczuk A; Wrona M; Pertyński T
Ginekol Pol; 2007 Dec; 78(12):986-9. PubMed ID: 18411925
[TBL] [Abstract][Full Text] [Related]
57. PTEN immunohistochemistry in endometrial hyperplasia: which are the optimal criteria for the diagnosis of precancer?
Travaglino A; Raffone A; Saccone G; Mascolo M; Pignatiello S; Mollo A; De Placido G; Insabato L; Zullo F
APMIS; 2019 Apr; 127(4):161-169. PubMed ID: 30803040
[TBL] [Abstract][Full Text] [Related]
58. Concurrent endometrial carcinoma in hysterectomy specimens in patients with histopathological diagnosis of endometrial hyperplasia in curettage specimens.
Dolanbay M; Kutuk MS; Uludag S; Bulut AN; Ozgun MT; Ozcelik B; Serin IS
Ginekol Pol; 2015 Oct; 86(10):753-8. PubMed ID: 26677585
[TBL] [Abstract][Full Text] [Related]
59. Endometrial hyperplasia with berrylike squamous metaplasia and pilomatrixomalike shadow cells. Report of an intriguing cytohistologic case.
Blandamura S; Boccato P; Spadaro M; Litta P; Chiarelli S
Acta Cytol; 2002; 46(5):887-92. PubMed ID: 12365225
[TBL] [Abstract][Full Text] [Related]
60. [Morphological diagnosis of endometrial intraepithelial neoplasia and expression of PTEN].
Zhou WX; Liang ZY; Gao J; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):393-6. PubMed ID: 19781346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
